Celltrion Sets Out Timetable For Omalizumab Trials

 
• By David Wallace
  
2022
Celltrion is aiming to complete a Phase III trial by 2022 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products